FGF21 muscle hormone associated with slow ALS progression and extended survival
“[…]we have identified FGF21 as a novel biomarker in ALS that is detected in multiple compartments including muscle, spinal cord, and circulation.”
2025-09-18
(Press-News.org)
“[…]we have identified FGF21 as a novel biomarker in ALS that is detected in multiple compartments including muscle, spinal cord, and circulation.”
BUFFALO, NY — September 18, 2025 — A new research paper was published in Volume 17, Issue 8 of Aging-US on August 9, 2025, titled “The myokine FGF21 associates with enhanced survival in ALS and mitigates stress-induced cytotoxicity.”
In this study, led by first author Abhishek Guha and corresponding author Peter H. King from the University of Alabama at Birmingham and the Birmingham Veterans Affairs Medical Center, researchers discovered that a hormone called FGF21, which is released by muscles, is elevated in people with amyotrophic lateral sclerosis (ALS) and may play a protective role. These findings are especially relevant because ALS is a fatal and currently incurable neurodegenerative disease.
Amyotrophic lateral sclerosis is an age-related and progressive condition that affects the nerve cells responsible for muscle control. While some treatments can slow the disease, there is still a need to understand why ALS progresses at different rates in different individuals.
“In a prior muscle miRNA sequencing investigation, we identified altered FGF pathways in ALS muscle, leading us to investigate FGF21.”
The research team analyzed muscle biopsies, spinal cord tissue, and blood samples from ALS patients and found that FGF21 levels were significantly elevated. This increase was particularly evident in atrophied muscle fibers—those that had shrunk due to nerve loss—and in the surrounding tissue. Importantly, patients with higher plasma levels of FGF21 showed slower loss of function and longer survival, with some living more than six years after diagnosis.
Using animal models and cultured cells, the researchers demonstrated that FGF21 levels rise even in the early, symptom-free stages of ALS. The hormone appeared to protect both muscle and motor neurons from stress-related damage. When added to stressed cells, FGF21 improved cell survival and reduced markers of cell death. In human muscle cells, FGF21 also supported the formation of new muscle fibers, a process known as myogenesis.
Blood tests revealed that patients with higher levels of FGF21 not only experienced slower disease progression but also tended to have a higher body mass index (BMI), a factor previously associated with longer survival in ALS. This suggests that FGF21 may reflect a patient’s ability to counteract ALS through natural protective mechanisms. It could also serve as a biomarker to monitor disease severity and potentially guide treatment decisions.
The study also investigated how FGF21 communicates with cells. It found that the hormone’s activity depends on a protein called β-Klotho, which was also altered in ALS-affected tissues. These changes were especially noticeable in motor neurons and muscle cells under stress, further highlighting FGF21’s role in the body’s response to damage.
While the study does not show that FGF21 can be used as a treatment, it highlights the hormone as a promising target for future research, clinical trials, and strategies to slow ALS progression by leveraging the body’s natural protective systems.
DOI: https://doi.org/10.18632/aging.206298
Corresponding author: Peter H. King – phking@uabmc.edu
Abstract video: https://www.youtube.com/watch?v=zEGMxQrxZxE
Keywords: aging, fibroblast growth factor, 21 β-Klotho, ALS biomarker, human skeletal muscle, motor neurons
Click here to sign up for free Altmetric alerts about this article.
______
To learn more about the journal, please visit our website at www.Aging-US.com and connect with us on social media at:
Facebook
X
Instagram
YouTube
LinkedIn
Reddit
Bluesky
Pinterest
Spotify, and available wherever you listen to podcasts
Click here to subscribe to Aging publication updates.
For media inquiries, please contact media@impactjournals.com.
END
ELSE PRESS RELEASES FROM THIS DATE:
2025-09-18
Music therapy could significantly reduce heart rate, blood pressure and patient–ventilator asynchronies for patients admitted to the cardiac intensive care unit (ICU), according to research being presented at ACC Latin America 2025 taking place September 18-20 in Mexico City.
Music therapy is the use of music and its elements to reduce stress and improve quality of life. A music therapist uses music therapy as a non-pharmacological and non-invasive intervention to improve a patient's physical, social, communicative, emotional, intellectual, and spiritual ...
2025-09-18
Despite improved statin use and cholesterol control, cardiovascular disease risk rose in Mexico between 2016 and 2023, according to a study being presented at ACC Latin America 2025 that used region-specific tools to more accurately predict the local disease burden.
Cardiovascular disease is the leading cause of death in the world, costing billions each year in care. Factors such as socioeconomics, demographics, hypertension, cholesterol, air pollution, obesity and more can play a role in the types of cardiovascular disease (CVD) burden a country or region may be most impacted by. Most models to predict cardiovascular disease risk use data ...
2025-09-18
WASHINGTON — Researchers have developed a flexible optical touch sensor that can simultaneously detect the strength and location of pressure with high sensitivity and stability. The advance in tactile sensing paves the way for next-generation robotic touch interfaces, advanced medical diagnostics and highly responsive wearable electronics.
“Unlike conventional optical tactile sensors, which tend to have a single input-output path, our sensor design achieves multiple optical channels by embedding polymer ...
2025-09-18
Achalasia is a disease caused by impaired movement of the esophagus. Patients experience food getting stuck and regurgitated, as well as chest pain. Currently, upper gastrointestinal endoscopy and high-resolution manometry are commonly used for diagnosis; however, these techniques are invasive.
Achalasia has some distinct features that are visible on plain chest X-ray such as twisting or dilation of the esophagus, and fluid retention. However, these signs are vague in most cases, and for this reason, X-rays normally require swallowing barium to diagnose the condition.
A research group from Osaka Metropolitan University ...
2025-09-18
Global warming poses a growing threat to human health and work performance. Currently, about 3.6 billion people worldwide live in areas highly susceptible to climate change. From 2000 to 2019, more than 480,000 heat-related deaths occurred globally each year. Extreme heat also impairs focus and productivity and worsens mood by elevating stress hormones and disrupting sleep. In response to the increasing frequency of heat waves, The Hong Kong Polytechnic University (PolyU) scholars are developing next-generation personal cooling solutions that push the limits of conventional clothing and promote ...
2025-09-18
A multi-institutional team led by Weill Cornell Medicine investigators has been awarded a five-year, $20.8 million grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, for advanced preclinical development of a promising experimental HIV vaccine.
A successful vaccine to prevent new HIV infections would be a major public health breakthrough. About 1.3 million people acquired HIV in 2024, according to the World Health Organization, and at the end of that year an estimated 41 million people were living with the ...
2025-09-18
Women suffering from long COVID have a greater risk1 of experiencing abnormal uterine bleeding2. The symptoms of the illness intensify during the perimenstrual and proliferative phases of the menstrual cycle, notably fatigue, headaches, and muscle pain. This bidirectional relationship between long COVID and menstrual disorders has been revealed by a French-British research team co-led by a CNRS researcher3. An inflammatory reaction is suspected of being behind this connection, after the discovery of an immune cell cluster in the endometrium of the patients receiving treatment. ...
2025-09-18
In global terms, the past year was distinguished not only by extreme drought but also by unusually heavy rainfall. These are the core findings of the report of the World Meteorological Organization (WMO) on the status of our planet's water resources that was published today. The regions most affected by severe drought conditions in 2024 were the Amazon basin and Southern Africa. There was excessive rainfall, for instance, in the African tropics and the resultant flooding resulted in the deaths of 2500 people while 4 million were forced from their homes. ...
2025-09-18
A research group from the National Cancer Research Centre (CNIO) has found that an alteration in the POT1 gene prevents lung tissue from regenerating, which over time makes breathing difficult.
The mutation prevents telomeres, the structures that protect chromosomes, from repairing.
According to the authors, understanding the effect of mutations like this “is critical to developing personalised therapies” against ‘telomere syndromes’, a group of diseases that includes pulmonary fibrosis and several cancer types.
Idiopathic pulmonary fibrosis is a potentially fatal disease currently without treatment, in which lung tissue develops scarring ...
2025-09-18
Researchers at the Nano Life Science Institute (WPI-NanoLSI), Kanazawa University, report in ACS Nano, how proteins in cells can be controllably activated through heating, an effect that can be used to initiate programmed cell death.
Cellular processes are governed by the activity of proteins. Being able to control the functioning of proteins is therefore highly relevant for the development of biotechnological tools. Doing so with high-enough spatial and temporal precision is hugely challenging, however. One approach for tackling this challenge, called thermogenetics, is based on the thermal response of certain proteins, with slight heating or cooling resulting in (de)activation. ...
LAST 30 PRESS RELEASES:
[Press-News.org] FGF21 muscle hormone associated with slow ALS progression and extended survival
“[…]we have identified FGF21 as a novel biomarker in ALS that is detected in multiple compartments including muscle, spinal cord, and circulation.”
